Literature DB >> 7298800

A dose-response curve for human growth hormone.

S D Frasier, G Costin, B M Lippe, T Aceto, P F Bunger.   

Abstract

Although human GH (hGH) has been administered to GH-deficient patients for over 20 yr, there are minimal published data on the relationship of response to dose. We have given hGH on the basis of body weight to 93 prepubertal GH-deficient patients over an initial 12 months of therapy. Their annual growth rate while receiving hGH was 5.58 +/- 2.30 (+/- SD) cm at a dose of 30 mIU/kg, three times a week (tiw; n = 27); 7.31 +/- 1.75 (+/- SD) cm at a dose of 60 mIU/kg, tiw (n = 38); 7.22 +/- 3.12 (+/- SD) cm at a dose of 80 mIU/kg, tiw (n = 12); and 8.94 +/- 1.19 cm (+/- SD) at a dose of 100 mIU/kg, tiw (n = 16). Doubling the dose from 30 to 60 mIU increased the mean rate of growth 1.3 times, and increasing the 30 mIU dose by a factor of 3.3 increased the mean rate of growth 1.6 times. The response (y) as a function of the log-dose (x) is defined by the equation y = -3.12 + 5.80 log x. When the effect of hGH is expressed as the increase in growth rate while receiving therapy, the log-dose relationship is defined by the equation y = -6.09 + 5.67 log x. This dose-response curve provides data which are useful in choosing the best dose of hGH for an individual patient. It also allows a more accurate projection of the costs and benefits of hGH therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298800     DOI: 10.1210/jcem-53-6-1213

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Optimization of growth hormone therapy in growth hormone deficient children.

Authors:  S M De Muinck Keizer-Schrama
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

2.  The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children.

Authors:  M Bozzola; G Radetti; S Pagani; M Draghi; G Aimaretti; G Rondini
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

3.  Evaluation of a pen injector system for growth hormone treatment.

Authors:  P D Gluckman; W S Cutfield
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

4.  Contribution of dose and frequency of administration to the therapeutic effect of growth hormone.

Authors:  P J Smith; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

5.  Diagnosis and treatment of short stature.

Authors:  P Owens; T Dahms
Journal:  Indian J Pediatr       Date:  1982 Jul-Aug       Impact factor: 1.967

6.  Effect of growth hormone on short normal children.

Authors:  P C Hindmarsh; C G Brook
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

7.  Comparison of growth hormone releasing hormone therapy and growth hormone therapy in growth hormone deficiency.

Authors:  O Butenandt; B Staudt
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

Review 8.  Clinical practice. Short stature in childhood--challenges and choices.

Authors:  David B Allen; Leona Cuttler
Journal:  N Engl J Med       Date:  2013-03-28       Impact factor: 91.245

Review 9.  Biosynthetic growth hormone therapy in children with growth hormone deficiency: experience at AIIMS, New Delhi.

Authors:  P S Menon; A Virmani; A K Sethi
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

10.  Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.

Authors:  Björn Andersson; Gunnel Hellgren; Andreas F M Nierop; Ze'ev Hochberg; Kerstin Albertsson-Wikland
Journal:  Proteome Sci       Date:  2009-11-02       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.